Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
| Revenue (Most Recent Fiscal Year) | $7.68B |
| Net Income (Most Recent Fiscal Year) | $903.70M |
| PE Ratio (Current Year Earnings Estimate) | 11.74 |
| PE Ratio (Trailing 12 Months) | 11.86 |
| PEG Ratio (Long Term Growth Estimate) | 2.16 |
| Price to Sales Ratio (Trailing 12 Months) | 2.40 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.49 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 7.07 |
| Pre-Tax Margin (Trailing 12 Months) | 13.65% |
| Net Margin (Trailing 12 Months) | 11.86% |
| Return on Equity (Trailing 12 Months) | 12.73% |
| Return on Assets (Trailing 12 Months) | 7.34% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.44 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.46 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.53 |
| Inventory Turnover (Trailing 12 Months) | 0.97 |
| Book Value per Share (Most Recent Fiscal Quarter) | $62.69 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.81 |
| Earnings per Share (Most Recent Fiscal Year) | $8.00 |
| Diluted Earnings per Share (Trailing 12 Months) | $4.52 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 197.85M |
| Free Float | 195.10M |
| Market Capitalization | $18.47B |
| Average Volume (Last 20 Days) | 2.91M |
| Beta (Past 60 Months) | 0.78 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.39% |
| Percentage Held By Institutions (Latest 13F Reports) | 88.89% |
| Annual Dividend (Based on Last Quarter) | $0.96 |
| Dividend Yield (Based on Last Quarter) | 1.03% |